What is Reviva Pharmaceuticals Holdings Inc. (RVPH) stock price today?

Reviva Pharmaceuticals Holdings Inc. (RVPH) currently trades at $0.87 per share. The stock has a market capitalization of $11.68M and a P/E ratio of —x.

Is RVPH stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Reviva Pharmaceuticals Holdings Inc. has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is —.

Is Reviva Pharmaceuticals Holdings Inc. financially healthy?

Reviva Pharmaceuticals Holdings Inc.'s Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of — places it in the —.

RVPH

Reviva Pharmaceuticals Holdings Inc.

NASDAQ: RVPH · HEALTHCARE · BIOTECHNOLOGY

$0.87

+0.43% today

Updated 2026-04-30

Market cap

$11.68M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.48

Dividend yield

—

52W range

$1 – $23

Volume

1.6M

Market cap

$11.68M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.48

Dividend yield

—

52W range

$1 – $23

Volume

1.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$58.20

+6585.81%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-24.59T

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-24.34M	$-39.26M	$-29.92M	$-19.86T	$-19.86T
EPS	—	—	—	—	$-5.48
Free cash flow	$-18.96M	$-28.32M	$-33.54M	$-24.59T	$-24.59T
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RVPH	$11.68M	25	4.3	3.0	5.0	4.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Reviva Pharmaceuticals Holdings Inc. trades at $0.87. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Reviva Pharmaceuticals Holdings Inc.'s stock price?

Reviva Pharmaceuticals Holdings Inc. (RVPH) trades at $0.87.

Is Reviva Pharmaceuticals Holdings Inc. overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Reviva Pharmaceuticals Holdings Inc. (RVPH)?

The analyst target price is $58.20, representing +6585.8% upside from the current price of $0.87.

Piotroski F-Score?

1/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.revivapharma.com

Quick metrics

P/S ratio—

ROE-420.00%

Beta0.64

50D MA$2.69

200D MA$7.65

Shares out0.01B

Float0.01B

Short ratio—

Avg volume1.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RVPH vs LLY →RVPH vs JNJ →RVPH vs ABBV →Stock screener →